EyePoint Statistics
NASDAQ: EYPTIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
3.32+0.15 (+4.73%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 3.30 -0.60%
EyePoint by the numbers
EyePoint has a market capitalization of $278.4 million based on 83.84M shares outstanding. With trailing EPS of $-3.75, EyePoint is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 50.1% below its 50-day average and 73.2% below its 200-day average.
Average daily trading volume is 3.95M shares, or about $13.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
EYPT valuation vs. peer median
| Metric | EYPT | Peer median | Difference |
|---|---|---|---|
| Market cap | $278.35M | $87.50M | +218% |
| Avg. volume | 3.95M | 629.67K | +527% |
Peer median across 8 companies: LAB, NAUT, QTRX, SEER, CIRC, RPID, PRPO, HBIO.
Valuation
- Market cap
- $278.35M
- EPS (TTM)
- $-3.75
- Shares outstanding
- 83.84M
Price and trading
- Previous close
- 3.17
- Open
- 3.11
- Day range
- 3.09 – 3.42
- 52-week range
- 3.05 – 19.11
- 52-week change
- -74.94%
- Beta
- —
- Volume
- 3.02M
- Average volume
- 3.95M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 278.35M
- Forward Pe
- -1.20
- Eps
- -3.75
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 19.11
- Week52 Low
- 3.05
- Avg Volume
- 3.95M
- Shares Outstanding
- 83.84M
- Ma50
- 6.66
- Ma200
- 12.40
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -82.63%
- Pct From52w Low
- 8.85%